In this strategy, 131I-labeled albumin-encapsulated liposomes, a β-ray emitting agent, facilitated tumor blood vascular permeability, resulting in an enhanced passive tumor accumulation of subsequently administered macromolecules. The gene discussed is ALB; the disease is neoplasm.